August 1, 2023
Bain Capital, Cinven, appoints Jefferies, J.P. Morgan, Morgan Stanley, and Rothschild for reviewing options, including a potential 2024 dual-track process, for their joint portfolio firm Stada Arzneimittel, a generic drug-maker, which it delisted in 2017 - according to sources (NKP Proprietary)
NKP | M&A Insights Proprietary
Headline from pre-deal coverage in M&A Insights